We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.77%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.31%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRCD
101
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $45M | 0.23% |
4,887,703
+279,490
| +6% | +$2.58M |
|
102
VeriSign
VRSN
$26.2B
| $44.9M | 0.23% |
919,460
-196,908
| -18% | -$9.81M |
|
103
Automatic Data Processing
ADP
$106B
| $44.2M | 0.23% |
635,044
-383,108
| -38% | -$26.1M |
|
|
GRFS
104
Grifois
GRFS
$5.36B
| $43.4M | 0.22% |
1,972,596
-131,648
| -6% | -$2.76M |
|
105
Aptiv
APTV
$12B
| $42.6M | 0.22% |
620,334
-244,104
| -28% | -$16.6M |
|
106
Colgate-Palmolive
CL
$73.1B
| $42.3M | 0.22% |
620,296
+464,783
| +299% | +$31.1M |
|
107
Dollar General
DG
$28B
| $42.2M | 0.22% |
734,890
+272,784
| +59% | +$15.6M |
|
108
Sempra
SRE
$57.9B
| $41.2M | 0.21% |
787,068
+168,992
| +27% | +$8.39M |
|
109
Devon Energy
DVN
$52.1B
| $39.9M | 0.2% |
+501,919
| New | +$36.5M |
|
110
Exelon
EXC
$47.2B
| $39.4M | 0.2% |
1,513,538
-585,991
| -28% | -$14.9M |
|
111
Public Service Enterprise Group
PEG
$38.2B
| $39.4M | 0.2% |
965,115
+435,231
| +82% | +$16.9M |
|
112
Air Products & Chemicals
APD
$65.7B
| $38.9M | 0.2% |
+327,267
| New | +$36.5M |
|
|
SWN
113
DELISTED
Southwestern Energy Company
SWN
| $38.3M | 0.2% |
+842,239
| New | +$39M |
|
|
CLR
114
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $37.4M | 0.19% |
+473,510
| New | +$32.9M |
|
|
CRZO
115
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $37.1M | 0.19% |
536,128
+314,689
| +142% | +$18.2M |
|
116
Equinor
EQNR
$97.7B
| $36.9M | 0.19% |
+1,197,867
| New | +$36.1M |
|
117
AutoZone
AZO
$49.2B
| $36.7M | 0.19% |
68,416
-120,630
| -64% | -$63.8M |
|
118
eBay
EBAY
$50.6B
| $36.3M | 0.19% |
+1,721,909
| New | +$37.5M |
|
119
Xcel Energy
XEL
$48.8B
| $35.6M | 0.18% |
1,106,094
+712,151
| +181% | +$22.1M |
|
120
Cardinal Health
CAH
$53.9B
| $35.3M | 0.18% |
515,549
+137,013
| +36% | +$9.33M |
|
|
ORAN
121
DELISTED
Orange
ORAN
| $35.2M | 0.18% |
2,230,568
+914,911
| +70% | +$14.6M |
|
122
Cenovus Energy
CVE
$55.7B
| $35.2M | 0.18% |
+1,085,042
| New | +$32.3M |
|
123
Aegon
AEG
$14B
| $34.6M | 0.18% |
5,803,083
+1,733,885
| +43% | +$10.4M |
|
|
124
Micron Technology
MU
$930B
| $34.4M | 0.18% |
1,042,809
-7,764,751
| -88% | -$212M |
|
125
Flex
FLEX
$41.7B
| $34.2M | 0.18% |
4,098,771
-3,552,718
| -46% | -$26.8M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.